Global site English

NYSE: TRIO 61.84 down −0.47 (−0.75%) Close 2 Nov 2026

Investor

TriOptimum reports first-quarter 2026 results

Revenue of $10.14 billion, up 4.4 percent; adjusted earnings per share of $1.19, up 10 percent. Full-year outlook reaffirmed.

Published
Reference
TRI-PR-20260429

TriOptimum Corporation (NYSE: TRIO) today reported results for the first quarter ended 31 March 2026.

  • Revenue of $10.14 billion, up 4.4 percent, and up 4.9 percent organically.
  • Orders of $10.92 billion, up 5.2 percent.
  • Segment margin of 11.9 percent, up 50 basis points.
  • Adjusted earnings per share of $1.19, up 10 percent.
  • Free cash flow of $0.86 billion, seasonally the lowest of the year.

Network Services and Medical Systems grew fastest. Orbital & Research Systems reported record operating efficiency at Citadel Station in the first quarter, which helped the division’s margin rise 90 basis points despite lower revenue.

The company reaffirmed its full-year 2026 outlook.

The Form 10-Q is available on the filings page.

About TriOptimum

TriOptimum Corporation (NYSE: TRIO) is a diversified technology company with six business segments: Security Products, Medical Systems, Network Services, Orbital & Research Systems, Resources & Materials and Agrisystems. Founded in Halsworth, England, in 1951, TriOptimum employs 118,400 people in 47 countries and reported revenue of $41.27 billion in 2025.

Contacts

Investors

Oliver Pike, Vice President, Investor Relations
investors@trioptimumcorp.com
+1 212 103 4400

Media

Corporate Communications
press@trioptimumcorp.com
+44 113 496 0731

Forward-looking statements

This release contains forward-looking statements, including statements about the company’s intentions regarding an appeal, the independent review of maintenance practices, its financial outlook and the timing of its results. These statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the outcome of regulatory proceedings, the review of the company’s other licensed systems and the factors described under “Risk Factors” in the company’s most recent annual report on Form 10-K. TriOptimum undertakes no obligation to update any forward-looking statement. See our full cautionary note.